Global Antithyroid Drug Market

Antithyroid Drug Comprehensive Study by Type (Propylthiouracil, Methimazole), Application (Hospital, Specialty Clinics), Distribution Channels (Hospital Dispensary, Retail Pharmacy, Online Pharmacy) Players and Region - Global Market Outlook to 2028

Antithyroid Drug Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
The antithyroid drugs industry contains antithyroid drugs that are highly used for the treatment of hyperthyroidism. Hyperthyroidism is produced by the overproduction of thyroid hormones among children, adults, and pregnant women. The anti-thyroid class of drugs is also termed thionamides which block the formation of thyroid hormone from the overactive thyroid gland. Graves’ disease is one of the straight reasons for hyperthyroidism, and the increase in the occurrence of Graves’ disease is a growing demand for antithyroid drugs. According to the stats, in the year 2018, nearly 384,500 people were suffering from Graves’ disease across the seven major markets around the globe among all the United States accounted highest reported cases with an occurrence of 1.2%.This growth is primarily driven by Prevalence of Graves Disease .

AttributesDetails
Study Period2018-2028
Base Year2022
Forecast Period2023-2028
Volume UnitK Tons
Value UnitUSD (Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


The Pharmaceuticals sector in the region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Mylan N.V. (United States), Abbott Laboratories (United States), GlaxoSmithKline plc (United Kingdom), Merck & Co. (United States), AbbVie, Inc. (United States), Pfizer, Inc (United States), RLC LABS (United States), Allergan, plc (United States), advanceCor GmbH. (Germany) and Apitope International NV. (Belgium), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Key Developments in the Market:
In September 2021, Merck, a publicly traded biopharmaceutical company acquired acquire Acceleron for USD180 per share in cash for an approximate total equity value of USD 11.5 billion. This acquisition helped company to expand its presence in antithyroid drug market
In November 2020, Pfizer Inc. Completed the transaction to spin off its Upjohn Business and combine it with Mylan N.V. to form Viatris Inc. this strategic move helped company to expand its presence in antithyroid drug marketThe companies are discovering the market in new geographical areas by adopting various strategic growth areas such as mergers & acquisitions, expansions, investments, new product launches, and others. The market key players are exploring new areas through growths and achievements across the globe to benefit from competitive advantage through combined synergies.

Influencing Trend:
Growing Demand Attributed from the North America Regions, among them, the United States Holds Major Market Share

Market Growth Drivers:
Prevalence of Graves Disease, Rising Geriatric Population and Technical Progress in Healthcare Industries

Challenges:
Skewed Player Distribution

Restraints:
Lack of Trained Professionals

Opportunities:
Increasing Penetration across Emerging Regions and Growing Healthcare Infrastructure

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mainly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the market's growth. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Data Sources of Antithyroid Drug Market Study

Primary Collection: InMail, LinkedIn Groups, Survey Monkey, Google, and Other professional Forums are some of the mediums utilized to gather primary data through key industry participants and appointees, subject-matter experts, C-level executives of Antithyroid Drug Industry, among others including independent industry consultants, experts, to obtain and verify critical qualitative commentary and opinion and quantitative statistics, to assess future market prospects.

The primary interviews and data collected as per the below protocols:
• By Designation: C-Level, D-Level, Others
• By Company Type: Tier 1, Tier 2, Tier 3

Secondary Data Sources such as Annual reports, Press releases, Analyst meetings, Conference calls, Investor presentations, Management statements, and SEC filings of Antithyroid Drug players along with Regulatory Sites, Association, World bank, etc were used as sources secondary set of data.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Antithyroid Drug Study Sheds Light on
— The Antithyroid Drug Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Antithyroid Drug industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Antithyroid Drug industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Propylthiouracil
  • Methimazole
By Application
  • Hospital
  • Specialty Clinics
By Distribution Channels
  • Hospital Dispensary
  • Retail Pharmacy
  • Online Pharmacy

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Prevalence of Graves Disease
      • 3.2.2. Rising Geriatric Population
      • 3.2.3. Technical Progress in Healthcare Industries
    • 3.3. Market Challenges
      • 3.3.1. Skewed Player Distribution
    • 3.4. Market Trends
      • 3.4.1. Growing Demand Attributed from the North America Regions, among them, the United States Holds Major Market Share
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Antithyroid Drug, by Type, Application, Distribution Channels and Region (value, volume and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Antithyroid Drug (Value)
      • 5.2.1. Global Antithyroid Drug by: Type (Value)
        • 5.2.1.1. Propylthiouracil
        • 5.2.1.2. Methimazole
      • 5.2.2. Global Antithyroid Drug by: Application (Value)
        • 5.2.2.1. Hospital
        • 5.2.2.2. Specialty Clinics
      • 5.2.3. Global Antithyroid Drug by: Distribution Channels (Value)
        • 5.2.3.1. Hospital Dispensary
        • 5.2.3.2. Retail Pharmacy
        • 5.2.3.3. Online Pharmacy
      • 5.2.4. Global Antithyroid Drug Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Antithyroid Drug (Volume)
      • 5.3.1. Global Antithyroid Drug by: Type (Volume)
        • 5.3.1.1. Propylthiouracil
        • 5.3.1.2. Methimazole
      • 5.3.2. Global Antithyroid Drug by: Application (Volume)
        • 5.3.2.1. Hospital
        • 5.3.2.2. Specialty Clinics
      • 5.3.3. Global Antithyroid Drug by: Distribution Channels (Volume)
        • 5.3.3.1. Hospital Dispensary
        • 5.3.3.2. Retail Pharmacy
        • 5.3.3.3. Online Pharmacy
      • 5.3.4. Global Antithyroid Drug Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Antithyroid Drug (Price)
      • 5.4.1. Global Antithyroid Drug by: Type (Price)
  • 6. Antithyroid Drug: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Mylan N.V. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Abbott Laboratories (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. GlaxoSmithKline plc (United Kingdom)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Merck & Co. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. AbbVie, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Pfizer, Inc (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. RLC LABS (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Allergan, plc (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. AdvanceCor GmbH. (Germany)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Apitope International NV. (Belgium)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Antithyroid Drug Sale, by Type, Application, Distribution Channels and Region (value, volume and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Antithyroid Drug (Value)
      • 7.2.1. Global Antithyroid Drug by: Type (Value)
        • 7.2.1.1. Propylthiouracil
        • 7.2.1.2. Methimazole
      • 7.2.2. Global Antithyroid Drug by: Application (Value)
        • 7.2.2.1. Hospital
        • 7.2.2.2. Specialty Clinics
      • 7.2.3. Global Antithyroid Drug by: Distribution Channels (Value)
        • 7.2.3.1. Hospital Dispensary
        • 7.2.3.2. Retail Pharmacy
        • 7.2.3.3. Online Pharmacy
      • 7.2.4. Global Antithyroid Drug Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Antithyroid Drug (Volume)
      • 7.3.1. Global Antithyroid Drug by: Type (Volume)
        • 7.3.1.1. Propylthiouracil
        • 7.3.1.2. Methimazole
      • 7.3.2. Global Antithyroid Drug by: Application (Volume)
        • 7.3.2.1. Hospital
        • 7.3.2.2. Specialty Clinics
      • 7.3.3. Global Antithyroid Drug by: Distribution Channels (Volume)
        • 7.3.3.1. Hospital Dispensary
        • 7.3.3.2. Retail Pharmacy
        • 7.3.3.3. Online Pharmacy
      • 7.3.4. Global Antithyroid Drug Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Antithyroid Drug (Price)
      • 7.4.1. Global Antithyroid Drug by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Antithyroid Drug: by Type(USD Million)
  • Table 2. Antithyroid Drug Propylthiouracil , by Region USD Million (2017-2022)
  • Table 3. Antithyroid Drug Methimazole , by Region USD Million (2017-2022)
  • Table 4. Antithyroid Drug: by Application(USD Million)
  • Table 5. Antithyroid Drug Hospital , by Region USD Million (2017-2022)
  • Table 6. Antithyroid Drug Specialty Clinics , by Region USD Million (2017-2022)
  • Table 7. Antithyroid Drug: by Distribution Channels(USD Million)
  • Table 8. Antithyroid Drug Hospital Dispensary , by Region USD Million (2017-2022)
  • Table 9. Antithyroid Drug Retail Pharmacy , by Region USD Million (2017-2022)
  • Table 10. Antithyroid Drug Online Pharmacy , by Region USD Million (2017-2022)
  • Table 11. South America Antithyroid Drug, by Country USD Million (2017-2022)
  • Table 12. South America Antithyroid Drug, by Type USD Million (2017-2022)
  • Table 13. South America Antithyroid Drug, by Application USD Million (2017-2022)
  • Table 14. South America Antithyroid Drug, by Distribution Channels USD Million (2017-2022)
  • Table 15. Brazil Antithyroid Drug, by Type USD Million (2017-2022)
  • Table 16. Brazil Antithyroid Drug, by Application USD Million (2017-2022)
  • Table 17. Brazil Antithyroid Drug, by Distribution Channels USD Million (2017-2022)
  • Table 18. Argentina Antithyroid Drug, by Type USD Million (2017-2022)
  • Table 19. Argentina Antithyroid Drug, by Application USD Million (2017-2022)
  • Table 20. Argentina Antithyroid Drug, by Distribution Channels USD Million (2017-2022)
  • Table 21. Rest of South America Antithyroid Drug, by Type USD Million (2017-2022)
  • Table 22. Rest of South America Antithyroid Drug, by Application USD Million (2017-2022)
  • Table 23. Rest of South America Antithyroid Drug, by Distribution Channels USD Million (2017-2022)
  • Table 24. Asia Pacific Antithyroid Drug, by Country USD Million (2017-2022)
  • Table 25. Asia Pacific Antithyroid Drug, by Type USD Million (2017-2022)
  • Table 26. Asia Pacific Antithyroid Drug, by Application USD Million (2017-2022)
  • Table 27. Asia Pacific Antithyroid Drug, by Distribution Channels USD Million (2017-2022)
  • Table 28. China Antithyroid Drug, by Type USD Million (2017-2022)
  • Table 29. China Antithyroid Drug, by Application USD Million (2017-2022)
  • Table 30. China Antithyroid Drug, by Distribution Channels USD Million (2017-2022)
  • Table 31. Japan Antithyroid Drug, by Type USD Million (2017-2022)
  • Table 32. Japan Antithyroid Drug, by Application USD Million (2017-2022)
  • Table 33. Japan Antithyroid Drug, by Distribution Channels USD Million (2017-2022)
  • Table 34. India Antithyroid Drug, by Type USD Million (2017-2022)
  • Table 35. India Antithyroid Drug, by Application USD Million (2017-2022)
  • Table 36. India Antithyroid Drug, by Distribution Channels USD Million (2017-2022)
  • Table 37. South Korea Antithyroid Drug, by Type USD Million (2017-2022)
  • Table 38. South Korea Antithyroid Drug, by Application USD Million (2017-2022)
  • Table 39. South Korea Antithyroid Drug, by Distribution Channels USD Million (2017-2022)
  • Table 40. Taiwan Antithyroid Drug, by Type USD Million (2017-2022)
  • Table 41. Taiwan Antithyroid Drug, by Application USD Million (2017-2022)
  • Table 42. Taiwan Antithyroid Drug, by Distribution Channels USD Million (2017-2022)
  • Table 43. Australia Antithyroid Drug, by Type USD Million (2017-2022)
  • Table 44. Australia Antithyroid Drug, by Application USD Million (2017-2022)
  • Table 45. Australia Antithyroid Drug, by Distribution Channels USD Million (2017-2022)
  • Table 46. Rest of Asia-Pacific Antithyroid Drug, by Type USD Million (2017-2022)
  • Table 47. Rest of Asia-Pacific Antithyroid Drug, by Application USD Million (2017-2022)
  • Table 48. Rest of Asia-Pacific Antithyroid Drug, by Distribution Channels USD Million (2017-2022)
  • Table 49. Europe Antithyroid Drug, by Country USD Million (2017-2022)
  • Table 50. Europe Antithyroid Drug, by Type USD Million (2017-2022)
  • Table 51. Europe Antithyroid Drug, by Application USD Million (2017-2022)
  • Table 52. Europe Antithyroid Drug, by Distribution Channels USD Million (2017-2022)
  • Table 53. Germany Antithyroid Drug, by Type USD Million (2017-2022)
  • Table 54. Germany Antithyroid Drug, by Application USD Million (2017-2022)
  • Table 55. Germany Antithyroid Drug, by Distribution Channels USD Million (2017-2022)
  • Table 56. France Antithyroid Drug, by Type USD Million (2017-2022)
  • Table 57. France Antithyroid Drug, by Application USD Million (2017-2022)
  • Table 58. France Antithyroid Drug, by Distribution Channels USD Million (2017-2022)
  • Table 59. Italy Antithyroid Drug, by Type USD Million (2017-2022)
  • Table 60. Italy Antithyroid Drug, by Application USD Million (2017-2022)
  • Table 61. Italy Antithyroid Drug, by Distribution Channels USD Million (2017-2022)
  • Table 62. United Kingdom Antithyroid Drug, by Type USD Million (2017-2022)
  • Table 63. United Kingdom Antithyroid Drug, by Application USD Million (2017-2022)
  • Table 64. United Kingdom Antithyroid Drug, by Distribution Channels USD Million (2017-2022)
  • Table 65. Netherlands Antithyroid Drug, by Type USD Million (2017-2022)
  • Table 66. Netherlands Antithyroid Drug, by Application USD Million (2017-2022)
  • Table 67. Netherlands Antithyroid Drug, by Distribution Channels USD Million (2017-2022)
  • Table 68. Rest of Europe Antithyroid Drug, by Type USD Million (2017-2022)
  • Table 69. Rest of Europe Antithyroid Drug, by Application USD Million (2017-2022)
  • Table 70. Rest of Europe Antithyroid Drug, by Distribution Channels USD Million (2017-2022)
  • Table 71. MEA Antithyroid Drug, by Country USD Million (2017-2022)
  • Table 72. MEA Antithyroid Drug, by Type USD Million (2017-2022)
  • Table 73. MEA Antithyroid Drug, by Application USD Million (2017-2022)
  • Table 74. MEA Antithyroid Drug, by Distribution Channels USD Million (2017-2022)
  • Table 75. Middle East Antithyroid Drug, by Type USD Million (2017-2022)
  • Table 76. Middle East Antithyroid Drug, by Application USD Million (2017-2022)
  • Table 77. Middle East Antithyroid Drug, by Distribution Channels USD Million (2017-2022)
  • Table 78. Africa Antithyroid Drug, by Type USD Million (2017-2022)
  • Table 79. Africa Antithyroid Drug, by Application USD Million (2017-2022)
  • Table 80. Africa Antithyroid Drug, by Distribution Channels USD Million (2017-2022)
  • Table 81. North America Antithyroid Drug, by Country USD Million (2017-2022)
  • Table 82. North America Antithyroid Drug, by Type USD Million (2017-2022)
  • Table 83. North America Antithyroid Drug, by Application USD Million (2017-2022)
  • Table 84. North America Antithyroid Drug, by Distribution Channels USD Million (2017-2022)
  • Table 85. United States Antithyroid Drug, by Type USD Million (2017-2022)
  • Table 86. United States Antithyroid Drug, by Application USD Million (2017-2022)
  • Table 87. United States Antithyroid Drug, by Distribution Channels USD Million (2017-2022)
  • Table 88. Canada Antithyroid Drug, by Type USD Million (2017-2022)
  • Table 89. Canada Antithyroid Drug, by Application USD Million (2017-2022)
  • Table 90. Canada Antithyroid Drug, by Distribution Channels USD Million (2017-2022)
  • Table 91. Mexico Antithyroid Drug, by Type USD Million (2017-2022)
  • Table 92. Mexico Antithyroid Drug, by Application USD Million (2017-2022)
  • Table 93. Mexico Antithyroid Drug, by Distribution Channels USD Million (2017-2022)
  • Table 94. Antithyroid Drug Sales: by Type(K Tons)
  • Table 95. Antithyroid Drug Sales Propylthiouracil , by Region K Tons (2017-2022)
  • Table 96. Antithyroid Drug Sales Methimazole , by Region K Tons (2017-2022)
  • Table 97. Antithyroid Drug Sales: by Application(K Tons)
  • Table 98. Antithyroid Drug Sales Hospital , by Region K Tons (2017-2022)
  • Table 99. Antithyroid Drug Sales Specialty Clinics , by Region K Tons (2017-2022)
  • Table 100. Antithyroid Drug Sales: by Distribution Channels(K Tons)
  • Table 101. Antithyroid Drug Sales Hospital Dispensary , by Region K Tons (2017-2022)
  • Table 102. Antithyroid Drug Sales Retail Pharmacy , by Region K Tons (2017-2022)
  • Table 103. Antithyroid Drug Sales Online Pharmacy , by Region K Tons (2017-2022)
  • Table 104. South America Antithyroid Drug Sales, by Country K Tons (2017-2022)
  • Table 105. South America Antithyroid Drug Sales, by Type K Tons (2017-2022)
  • Table 106. South America Antithyroid Drug Sales, by Application K Tons (2017-2022)
  • Table 107. South America Antithyroid Drug Sales, by Distribution Channels K Tons (2017-2022)
  • Table 108. Brazil Antithyroid Drug Sales, by Type K Tons (2017-2022)
  • Table 109. Brazil Antithyroid Drug Sales, by Application K Tons (2017-2022)
  • Table 110. Brazil Antithyroid Drug Sales, by Distribution Channels K Tons (2017-2022)
  • Table 111. Argentina Antithyroid Drug Sales, by Type K Tons (2017-2022)
  • Table 112. Argentina Antithyroid Drug Sales, by Application K Tons (2017-2022)
  • Table 113. Argentina Antithyroid Drug Sales, by Distribution Channels K Tons (2017-2022)
  • Table 114. Rest of South America Antithyroid Drug Sales, by Type K Tons (2017-2022)
  • Table 115. Rest of South America Antithyroid Drug Sales, by Application K Tons (2017-2022)
  • Table 116. Rest of South America Antithyroid Drug Sales, by Distribution Channels K Tons (2017-2022)
  • Table 117. Asia Pacific Antithyroid Drug Sales, by Country K Tons (2017-2022)
  • Table 118. Asia Pacific Antithyroid Drug Sales, by Type K Tons (2017-2022)
  • Table 119. Asia Pacific Antithyroid Drug Sales, by Application K Tons (2017-2022)
  • Table 120. Asia Pacific Antithyroid Drug Sales, by Distribution Channels K Tons (2017-2022)
  • Table 121. China Antithyroid Drug Sales, by Type K Tons (2017-2022)
  • Table 122. China Antithyroid Drug Sales, by Application K Tons (2017-2022)
  • Table 123. China Antithyroid Drug Sales, by Distribution Channels K Tons (2017-2022)
  • Table 124. Japan Antithyroid Drug Sales, by Type K Tons (2017-2022)
  • Table 125. Japan Antithyroid Drug Sales, by Application K Tons (2017-2022)
  • Table 126. Japan Antithyroid Drug Sales, by Distribution Channels K Tons (2017-2022)
  • Table 127. India Antithyroid Drug Sales, by Type K Tons (2017-2022)
  • Table 128. India Antithyroid Drug Sales, by Application K Tons (2017-2022)
  • Table 129. India Antithyroid Drug Sales, by Distribution Channels K Tons (2017-2022)
  • Table 130. South Korea Antithyroid Drug Sales, by Type K Tons (2017-2022)
  • Table 131. South Korea Antithyroid Drug Sales, by Application K Tons (2017-2022)
  • Table 132. South Korea Antithyroid Drug Sales, by Distribution Channels K Tons (2017-2022)
  • Table 133. Taiwan Antithyroid Drug Sales, by Type K Tons (2017-2022)
  • Table 134. Taiwan Antithyroid Drug Sales, by Application K Tons (2017-2022)
  • Table 135. Taiwan Antithyroid Drug Sales, by Distribution Channels K Tons (2017-2022)
  • Table 136. Australia Antithyroid Drug Sales, by Type K Tons (2017-2022)
  • Table 137. Australia Antithyroid Drug Sales, by Application K Tons (2017-2022)
  • Table 138. Australia Antithyroid Drug Sales, by Distribution Channels K Tons (2017-2022)
  • Table 139. Rest of Asia-Pacific Antithyroid Drug Sales, by Type K Tons (2017-2022)
  • Table 140. Rest of Asia-Pacific Antithyroid Drug Sales, by Application K Tons (2017-2022)
  • Table 141. Rest of Asia-Pacific Antithyroid Drug Sales, by Distribution Channels K Tons (2017-2022)
  • Table 142. Europe Antithyroid Drug Sales, by Country K Tons (2017-2022)
  • Table 143. Europe Antithyroid Drug Sales, by Type K Tons (2017-2022)
  • Table 144. Europe Antithyroid Drug Sales, by Application K Tons (2017-2022)
  • Table 145. Europe Antithyroid Drug Sales, by Distribution Channels K Tons (2017-2022)
  • Table 146. Germany Antithyroid Drug Sales, by Type K Tons (2017-2022)
  • Table 147. Germany Antithyroid Drug Sales, by Application K Tons (2017-2022)
  • Table 148. Germany Antithyroid Drug Sales, by Distribution Channels K Tons (2017-2022)
  • Table 149. France Antithyroid Drug Sales, by Type K Tons (2017-2022)
  • Table 150. France Antithyroid Drug Sales, by Application K Tons (2017-2022)
  • Table 151. France Antithyroid Drug Sales, by Distribution Channels K Tons (2017-2022)
  • Table 152. Italy Antithyroid Drug Sales, by Type K Tons (2017-2022)
  • Table 153. Italy Antithyroid Drug Sales, by Application K Tons (2017-2022)
  • Table 154. Italy Antithyroid Drug Sales, by Distribution Channels K Tons (2017-2022)
  • Table 155. United Kingdom Antithyroid Drug Sales, by Type K Tons (2017-2022)
  • Table 156. United Kingdom Antithyroid Drug Sales, by Application K Tons (2017-2022)
  • Table 157. United Kingdom Antithyroid Drug Sales, by Distribution Channels K Tons (2017-2022)
  • Table 158. Netherlands Antithyroid Drug Sales, by Type K Tons (2017-2022)
  • Table 159. Netherlands Antithyroid Drug Sales, by Application K Tons (2017-2022)
  • Table 160. Netherlands Antithyroid Drug Sales, by Distribution Channels K Tons (2017-2022)
  • Table 161. Rest of Europe Antithyroid Drug Sales, by Type K Tons (2017-2022)
  • Table 162. Rest of Europe Antithyroid Drug Sales, by Application K Tons (2017-2022)
  • Table 163. Rest of Europe Antithyroid Drug Sales, by Distribution Channels K Tons (2017-2022)
  • Table 164. MEA Antithyroid Drug Sales, by Country K Tons (2017-2022)
  • Table 165. MEA Antithyroid Drug Sales, by Type K Tons (2017-2022)
  • Table 166. MEA Antithyroid Drug Sales, by Application K Tons (2017-2022)
  • Table 167. MEA Antithyroid Drug Sales, by Distribution Channels K Tons (2017-2022)
  • Table 168. Middle East Antithyroid Drug Sales, by Type K Tons (2017-2022)
  • Table 169. Middle East Antithyroid Drug Sales, by Application K Tons (2017-2022)
  • Table 170. Middle East Antithyroid Drug Sales, by Distribution Channels K Tons (2017-2022)
  • Table 171. Africa Antithyroid Drug Sales, by Type K Tons (2017-2022)
  • Table 172. Africa Antithyroid Drug Sales, by Application K Tons (2017-2022)
  • Table 173. Africa Antithyroid Drug Sales, by Distribution Channels K Tons (2017-2022)
  • Table 174. North America Antithyroid Drug Sales, by Country K Tons (2017-2022)
  • Table 175. North America Antithyroid Drug Sales, by Type K Tons (2017-2022)
  • Table 176. North America Antithyroid Drug Sales, by Application K Tons (2017-2022)
  • Table 177. North America Antithyroid Drug Sales, by Distribution Channels K Tons (2017-2022)
  • Table 178. United States Antithyroid Drug Sales, by Type K Tons (2017-2022)
  • Table 179. United States Antithyroid Drug Sales, by Application K Tons (2017-2022)
  • Table 180. United States Antithyroid Drug Sales, by Distribution Channels K Tons (2017-2022)
  • Table 181. Canada Antithyroid Drug Sales, by Type K Tons (2017-2022)
  • Table 182. Canada Antithyroid Drug Sales, by Application K Tons (2017-2022)
  • Table 183. Canada Antithyroid Drug Sales, by Distribution Channels K Tons (2017-2022)
  • Table 184. Mexico Antithyroid Drug Sales, by Type K Tons (2017-2022)
  • Table 185. Mexico Antithyroid Drug Sales, by Application K Tons (2017-2022)
  • Table 186. Mexico Antithyroid Drug Sales, by Distribution Channels K Tons (2017-2022)
  • Table 187. Antithyroid Drug: by Type(USD/Units)
  • Table 188. Company Basic Information, Sales Area and Its Competitors
  • Table 189. Company Basic Information, Sales Area and Its Competitors
  • Table 190. Company Basic Information, Sales Area and Its Competitors
  • Table 191. Company Basic Information, Sales Area and Its Competitors
  • Table 192. Company Basic Information, Sales Area and Its Competitors
  • Table 193. Company Basic Information, Sales Area and Its Competitors
  • Table 194. Company Basic Information, Sales Area and Its Competitors
  • Table 195. Company Basic Information, Sales Area and Its Competitors
  • Table 196. Company Basic Information, Sales Area and Its Competitors
  • Table 197. Company Basic Information, Sales Area and Its Competitors
  • Table 198. Antithyroid Drug: by Type(USD Million)
  • Table 199. Antithyroid Drug Propylthiouracil , by Region USD Million (2023-2028)
  • Table 200. Antithyroid Drug Methimazole , by Region USD Million (2023-2028)
  • Table 201. Antithyroid Drug: by Application(USD Million)
  • Table 202. Antithyroid Drug Hospital , by Region USD Million (2023-2028)
  • Table 203. Antithyroid Drug Specialty Clinics , by Region USD Million (2023-2028)
  • Table 204. Antithyroid Drug: by Distribution Channels(USD Million)
  • Table 205. Antithyroid Drug Hospital Dispensary , by Region USD Million (2023-2028)
  • Table 206. Antithyroid Drug Retail Pharmacy , by Region USD Million (2023-2028)
  • Table 207. Antithyroid Drug Online Pharmacy , by Region USD Million (2023-2028)
  • Table 208. South America Antithyroid Drug, by Country USD Million (2023-2028)
  • Table 209. South America Antithyroid Drug, by Type USD Million (2023-2028)
  • Table 210. South America Antithyroid Drug, by Application USD Million (2023-2028)
  • Table 211. South America Antithyroid Drug, by Distribution Channels USD Million (2023-2028)
  • Table 212. Brazil Antithyroid Drug, by Type USD Million (2023-2028)
  • Table 213. Brazil Antithyroid Drug, by Application USD Million (2023-2028)
  • Table 214. Brazil Antithyroid Drug, by Distribution Channels USD Million (2023-2028)
  • Table 215. Argentina Antithyroid Drug, by Type USD Million (2023-2028)
  • Table 216. Argentina Antithyroid Drug, by Application USD Million (2023-2028)
  • Table 217. Argentina Antithyroid Drug, by Distribution Channels USD Million (2023-2028)
  • Table 218. Rest of South America Antithyroid Drug, by Type USD Million (2023-2028)
  • Table 219. Rest of South America Antithyroid Drug, by Application USD Million (2023-2028)
  • Table 220. Rest of South America Antithyroid Drug, by Distribution Channels USD Million (2023-2028)
  • Table 221. Asia Pacific Antithyroid Drug, by Country USD Million (2023-2028)
  • Table 222. Asia Pacific Antithyroid Drug, by Type USD Million (2023-2028)
  • Table 223. Asia Pacific Antithyroid Drug, by Application USD Million (2023-2028)
  • Table 224. Asia Pacific Antithyroid Drug, by Distribution Channels USD Million (2023-2028)
  • Table 225. China Antithyroid Drug, by Type USD Million (2023-2028)
  • Table 226. China Antithyroid Drug, by Application USD Million (2023-2028)
  • Table 227. China Antithyroid Drug, by Distribution Channels USD Million (2023-2028)
  • Table 228. Japan Antithyroid Drug, by Type USD Million (2023-2028)
  • Table 229. Japan Antithyroid Drug, by Application USD Million (2023-2028)
  • Table 230. Japan Antithyroid Drug, by Distribution Channels USD Million (2023-2028)
  • Table 231. India Antithyroid Drug, by Type USD Million (2023-2028)
  • Table 232. India Antithyroid Drug, by Application USD Million (2023-2028)
  • Table 233. India Antithyroid Drug, by Distribution Channels USD Million (2023-2028)
  • Table 234. South Korea Antithyroid Drug, by Type USD Million (2023-2028)
  • Table 235. South Korea Antithyroid Drug, by Application USD Million (2023-2028)
  • Table 236. South Korea Antithyroid Drug, by Distribution Channels USD Million (2023-2028)
  • Table 237. Taiwan Antithyroid Drug, by Type USD Million (2023-2028)
  • Table 238. Taiwan Antithyroid Drug, by Application USD Million (2023-2028)
  • Table 239. Taiwan Antithyroid Drug, by Distribution Channels USD Million (2023-2028)
  • Table 240. Australia Antithyroid Drug, by Type USD Million (2023-2028)
  • Table 241. Australia Antithyroid Drug, by Application USD Million (2023-2028)
  • Table 242. Australia Antithyroid Drug, by Distribution Channels USD Million (2023-2028)
  • Table 243. Rest of Asia-Pacific Antithyroid Drug, by Type USD Million (2023-2028)
  • Table 244. Rest of Asia-Pacific Antithyroid Drug, by Application USD Million (2023-2028)
  • Table 245. Rest of Asia-Pacific Antithyroid Drug, by Distribution Channels USD Million (2023-2028)
  • Table 246. Europe Antithyroid Drug, by Country USD Million (2023-2028)
  • Table 247. Europe Antithyroid Drug, by Type USD Million (2023-2028)
  • Table 248. Europe Antithyroid Drug, by Application USD Million (2023-2028)
  • Table 249. Europe Antithyroid Drug, by Distribution Channels USD Million (2023-2028)
  • Table 250. Germany Antithyroid Drug, by Type USD Million (2023-2028)
  • Table 251. Germany Antithyroid Drug, by Application USD Million (2023-2028)
  • Table 252. Germany Antithyroid Drug, by Distribution Channels USD Million (2023-2028)
  • Table 253. France Antithyroid Drug, by Type USD Million (2023-2028)
  • Table 254. France Antithyroid Drug, by Application USD Million (2023-2028)
  • Table 255. France Antithyroid Drug, by Distribution Channels USD Million (2023-2028)
  • Table 256. Italy Antithyroid Drug, by Type USD Million (2023-2028)
  • Table 257. Italy Antithyroid Drug, by Application USD Million (2023-2028)
  • Table 258. Italy Antithyroid Drug, by Distribution Channels USD Million (2023-2028)
  • Table 259. United Kingdom Antithyroid Drug, by Type USD Million (2023-2028)
  • Table 260. United Kingdom Antithyroid Drug, by Application USD Million (2023-2028)
  • Table 261. United Kingdom Antithyroid Drug, by Distribution Channels USD Million (2023-2028)
  • Table 262. Netherlands Antithyroid Drug, by Type USD Million (2023-2028)
  • Table 263. Netherlands Antithyroid Drug, by Application USD Million (2023-2028)
  • Table 264. Netherlands Antithyroid Drug, by Distribution Channels USD Million (2023-2028)
  • Table 265. Rest of Europe Antithyroid Drug, by Type USD Million (2023-2028)
  • Table 266. Rest of Europe Antithyroid Drug, by Application USD Million (2023-2028)
  • Table 267. Rest of Europe Antithyroid Drug, by Distribution Channels USD Million (2023-2028)
  • Table 268. MEA Antithyroid Drug, by Country USD Million (2023-2028)
  • Table 269. MEA Antithyroid Drug, by Type USD Million (2023-2028)
  • Table 270. MEA Antithyroid Drug, by Application USD Million (2023-2028)
  • Table 271. MEA Antithyroid Drug, by Distribution Channels USD Million (2023-2028)
  • Table 272. Middle East Antithyroid Drug, by Type USD Million (2023-2028)
  • Table 273. Middle East Antithyroid Drug, by Application USD Million (2023-2028)
  • Table 274. Middle East Antithyroid Drug, by Distribution Channels USD Million (2023-2028)
  • Table 275. Africa Antithyroid Drug, by Type USD Million (2023-2028)
  • Table 276. Africa Antithyroid Drug, by Application USD Million (2023-2028)
  • Table 277. Africa Antithyroid Drug, by Distribution Channels USD Million (2023-2028)
  • Table 278. North America Antithyroid Drug, by Country USD Million (2023-2028)
  • Table 279. North America Antithyroid Drug, by Type USD Million (2023-2028)
  • Table 280. North America Antithyroid Drug, by Application USD Million (2023-2028)
  • Table 281. North America Antithyroid Drug, by Distribution Channels USD Million (2023-2028)
  • Table 282. United States Antithyroid Drug, by Type USD Million (2023-2028)
  • Table 283. United States Antithyroid Drug, by Application USD Million (2023-2028)
  • Table 284. United States Antithyroid Drug, by Distribution Channels USD Million (2023-2028)
  • Table 285. Canada Antithyroid Drug, by Type USD Million (2023-2028)
  • Table 286. Canada Antithyroid Drug, by Application USD Million (2023-2028)
  • Table 287. Canada Antithyroid Drug, by Distribution Channels USD Million (2023-2028)
  • Table 288. Mexico Antithyroid Drug, by Type USD Million (2023-2028)
  • Table 289. Mexico Antithyroid Drug, by Application USD Million (2023-2028)
  • Table 290. Mexico Antithyroid Drug, by Distribution Channels USD Million (2023-2028)
  • Table 291. Antithyroid Drug Sales: by Type(K Tons)
  • Table 292. Antithyroid Drug Sales Propylthiouracil , by Region K Tons (2023-2028)
  • Table 293. Antithyroid Drug Sales Methimazole , by Region K Tons (2023-2028)
  • Table 294. Antithyroid Drug Sales: by Application(K Tons)
  • Table 295. Antithyroid Drug Sales Hospital , by Region K Tons (2023-2028)
  • Table 296. Antithyroid Drug Sales Specialty Clinics , by Region K Tons (2023-2028)
  • Table 297. Antithyroid Drug Sales: by Distribution Channels(K Tons)
  • Table 298. Antithyroid Drug Sales Hospital Dispensary , by Region K Tons (2023-2028)
  • Table 299. Antithyroid Drug Sales Retail Pharmacy , by Region K Tons (2023-2028)
  • Table 300. Antithyroid Drug Sales Online Pharmacy , by Region K Tons (2023-2028)
  • Table 301. South America Antithyroid Drug Sales, by Country K Tons (2023-2028)
  • Table 302. South America Antithyroid Drug Sales, by Type K Tons (2023-2028)
  • Table 303. South America Antithyroid Drug Sales, by Application K Tons (2023-2028)
  • Table 304. South America Antithyroid Drug Sales, by Distribution Channels K Tons (2023-2028)
  • Table 305. Brazil Antithyroid Drug Sales, by Type K Tons (2023-2028)
  • Table 306. Brazil Antithyroid Drug Sales, by Application K Tons (2023-2028)
  • Table 307. Brazil Antithyroid Drug Sales, by Distribution Channels K Tons (2023-2028)
  • Table 308. Argentina Antithyroid Drug Sales, by Type K Tons (2023-2028)
  • Table 309. Argentina Antithyroid Drug Sales, by Application K Tons (2023-2028)
  • Table 310. Argentina Antithyroid Drug Sales, by Distribution Channels K Tons (2023-2028)
  • Table 311. Rest of South America Antithyroid Drug Sales, by Type K Tons (2023-2028)
  • Table 312. Rest of South America Antithyroid Drug Sales, by Application K Tons (2023-2028)
  • Table 313. Rest of South America Antithyroid Drug Sales, by Distribution Channels K Tons (2023-2028)
  • Table 314. Asia Pacific Antithyroid Drug Sales, by Country K Tons (2023-2028)
  • Table 315. Asia Pacific Antithyroid Drug Sales, by Type K Tons (2023-2028)
  • Table 316. Asia Pacific Antithyroid Drug Sales, by Application K Tons (2023-2028)
  • Table 317. Asia Pacific Antithyroid Drug Sales, by Distribution Channels K Tons (2023-2028)
  • Table 318. China Antithyroid Drug Sales, by Type K Tons (2023-2028)
  • Table 319. China Antithyroid Drug Sales, by Application K Tons (2023-2028)
  • Table 320. China Antithyroid Drug Sales, by Distribution Channels K Tons (2023-2028)
  • Table 321. Japan Antithyroid Drug Sales, by Type K Tons (2023-2028)
  • Table 322. Japan Antithyroid Drug Sales, by Application K Tons (2023-2028)
  • Table 323. Japan Antithyroid Drug Sales, by Distribution Channels K Tons (2023-2028)
  • Table 324. India Antithyroid Drug Sales, by Type K Tons (2023-2028)
  • Table 325. India Antithyroid Drug Sales, by Application K Tons (2023-2028)
  • Table 326. India Antithyroid Drug Sales, by Distribution Channels K Tons (2023-2028)
  • Table 327. South Korea Antithyroid Drug Sales, by Type K Tons (2023-2028)
  • Table 328. South Korea Antithyroid Drug Sales, by Application K Tons (2023-2028)
  • Table 329. South Korea Antithyroid Drug Sales, by Distribution Channels K Tons (2023-2028)
  • Table 330. Taiwan Antithyroid Drug Sales, by Type K Tons (2023-2028)
  • Table 331. Taiwan Antithyroid Drug Sales, by Application K Tons (2023-2028)
  • Table 332. Taiwan Antithyroid Drug Sales, by Distribution Channels K Tons (2023-2028)
  • Table 333. Australia Antithyroid Drug Sales, by Type K Tons (2023-2028)
  • Table 334. Australia Antithyroid Drug Sales, by Application K Tons (2023-2028)
  • Table 335. Australia Antithyroid Drug Sales, by Distribution Channels K Tons (2023-2028)
  • Table 336. Rest of Asia-Pacific Antithyroid Drug Sales, by Type K Tons (2023-2028)
  • Table 337. Rest of Asia-Pacific Antithyroid Drug Sales, by Application K Tons (2023-2028)
  • Table 338. Rest of Asia-Pacific Antithyroid Drug Sales, by Distribution Channels K Tons (2023-2028)
  • Table 339. Europe Antithyroid Drug Sales, by Country K Tons (2023-2028)
  • Table 340. Europe Antithyroid Drug Sales, by Type K Tons (2023-2028)
  • Table 341. Europe Antithyroid Drug Sales, by Application K Tons (2023-2028)
  • Table 342. Europe Antithyroid Drug Sales, by Distribution Channels K Tons (2023-2028)
  • Table 343. Germany Antithyroid Drug Sales, by Type K Tons (2023-2028)
  • Table 344. Germany Antithyroid Drug Sales, by Application K Tons (2023-2028)
  • Table 345. Germany Antithyroid Drug Sales, by Distribution Channels K Tons (2023-2028)
  • Table 346. France Antithyroid Drug Sales, by Type K Tons (2023-2028)
  • Table 347. France Antithyroid Drug Sales, by Application K Tons (2023-2028)
  • Table 348. France Antithyroid Drug Sales, by Distribution Channels K Tons (2023-2028)
  • Table 349. Italy Antithyroid Drug Sales, by Type K Tons (2023-2028)
  • Table 350. Italy Antithyroid Drug Sales, by Application K Tons (2023-2028)
  • Table 351. Italy Antithyroid Drug Sales, by Distribution Channels K Tons (2023-2028)
  • Table 352. United Kingdom Antithyroid Drug Sales, by Type K Tons (2023-2028)
  • Table 353. United Kingdom Antithyroid Drug Sales, by Application K Tons (2023-2028)
  • Table 354. United Kingdom Antithyroid Drug Sales, by Distribution Channels K Tons (2023-2028)
  • Table 355. Netherlands Antithyroid Drug Sales, by Type K Tons (2023-2028)
  • Table 356. Netherlands Antithyroid Drug Sales, by Application K Tons (2023-2028)
  • Table 357. Netherlands Antithyroid Drug Sales, by Distribution Channels K Tons (2023-2028)
  • Table 358. Rest of Europe Antithyroid Drug Sales, by Type K Tons (2023-2028)
  • Table 359. Rest of Europe Antithyroid Drug Sales, by Application K Tons (2023-2028)
  • Table 360. Rest of Europe Antithyroid Drug Sales, by Distribution Channels K Tons (2023-2028)
  • Table 361. MEA Antithyroid Drug Sales, by Country K Tons (2023-2028)
  • Table 362. MEA Antithyroid Drug Sales, by Type K Tons (2023-2028)
  • Table 363. MEA Antithyroid Drug Sales, by Application K Tons (2023-2028)
  • Table 364. MEA Antithyroid Drug Sales, by Distribution Channels K Tons (2023-2028)
  • Table 365. Middle East Antithyroid Drug Sales, by Type K Tons (2023-2028)
  • Table 366. Middle East Antithyroid Drug Sales, by Application K Tons (2023-2028)
  • Table 367. Middle East Antithyroid Drug Sales, by Distribution Channels K Tons (2023-2028)
  • Table 368. Africa Antithyroid Drug Sales, by Type K Tons (2023-2028)
  • Table 369. Africa Antithyroid Drug Sales, by Application K Tons (2023-2028)
  • Table 370. Africa Antithyroid Drug Sales, by Distribution Channels K Tons (2023-2028)
  • Table 371. North America Antithyroid Drug Sales, by Country K Tons (2023-2028)
  • Table 372. North America Antithyroid Drug Sales, by Type K Tons (2023-2028)
  • Table 373. North America Antithyroid Drug Sales, by Application K Tons (2023-2028)
  • Table 374. North America Antithyroid Drug Sales, by Distribution Channels K Tons (2023-2028)
  • Table 375. United States Antithyroid Drug Sales, by Type K Tons (2023-2028)
  • Table 376. United States Antithyroid Drug Sales, by Application K Tons (2023-2028)
  • Table 377. United States Antithyroid Drug Sales, by Distribution Channels K Tons (2023-2028)
  • Table 378. Canada Antithyroid Drug Sales, by Type K Tons (2023-2028)
  • Table 379. Canada Antithyroid Drug Sales, by Application K Tons (2023-2028)
  • Table 380. Canada Antithyroid Drug Sales, by Distribution Channels K Tons (2023-2028)
  • Table 381. Mexico Antithyroid Drug Sales, by Type K Tons (2023-2028)
  • Table 382. Mexico Antithyroid Drug Sales, by Application K Tons (2023-2028)
  • Table 383. Mexico Antithyroid Drug Sales, by Distribution Channels K Tons (2023-2028)
  • Table 384. Antithyroid Drug: by Type(USD/Units)
  • Table 385. Research Programs/Design for This Report
  • Table 386. Key Data Information from Secondary Sources
  • Table 387. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Antithyroid Drug: by Type USD Million (2017-2022)
  • Figure 5. Global Antithyroid Drug: by Application USD Million (2017-2022)
  • Figure 6. Global Antithyroid Drug: by Distribution Channels USD Million (2017-2022)
  • Figure 7. South America Antithyroid Drug Share (%), by Country
  • Figure 8. Asia Pacific Antithyroid Drug Share (%), by Country
  • Figure 9. Europe Antithyroid Drug Share (%), by Country
  • Figure 10. MEA Antithyroid Drug Share (%), by Country
  • Figure 11. North America Antithyroid Drug Share (%), by Country
  • Figure 12. Global Antithyroid Drug: by Type K Tons (2017-2022)
  • Figure 13. Global Antithyroid Drug: by Application K Tons (2017-2022)
  • Figure 14. Global Antithyroid Drug: by Distribution Channels K Tons (2017-2022)
  • Figure 15. South America Antithyroid Drug Share (%), by Country
  • Figure 16. Asia Pacific Antithyroid Drug Share (%), by Country
  • Figure 17. Europe Antithyroid Drug Share (%), by Country
  • Figure 18. MEA Antithyroid Drug Share (%), by Country
  • Figure 19. North America Antithyroid Drug Share (%), by Country
  • Figure 20. Global Antithyroid Drug: by Type USD/Units (2017-2022)
  • Figure 21. Global Antithyroid Drug share by Players 2022 (%)
  • Figure 22. Global Antithyroid Drug share by Players (Top 3) 2022(%)
  • Figure 23. Global Antithyroid Drug share by Players (Top 5) 2022(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. Mylan N.V. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Mylan N.V. (United States) Revenue: by Geography 2022
  • Figure 27. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 28. Abbott Laboratories (United States) Revenue: by Geography 2022
  • Figure 29. GlaxoSmithKline plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 30. GlaxoSmithKline plc (United Kingdom) Revenue: by Geography 2022
  • Figure 31. Merck & Co. (United States) Revenue, Net Income and Gross profit
  • Figure 32. Merck & Co. (United States) Revenue: by Geography 2022
  • Figure 33. AbbVie, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 34. AbbVie, Inc. (United States) Revenue: by Geography 2022
  • Figure 35. Pfizer, Inc (United States) Revenue, Net Income and Gross profit
  • Figure 36. Pfizer, Inc (United States) Revenue: by Geography 2022
  • Figure 37. RLC LABS (United States) Revenue, Net Income and Gross profit
  • Figure 38. RLC LABS (United States) Revenue: by Geography 2022
  • Figure 39. Allergan, plc (United States) Revenue, Net Income and Gross profit
  • Figure 40. Allergan, plc (United States) Revenue: by Geography 2022
  • Figure 41. AdvanceCor GmbH. (Germany) Revenue, Net Income and Gross profit
  • Figure 42. AdvanceCor GmbH. (Germany) Revenue: by Geography 2022
  • Figure 43. Apitope International NV. (Belgium) Revenue, Net Income and Gross profit
  • Figure 44. Apitope International NV. (Belgium) Revenue: by Geography 2022
  • Figure 45. Global Antithyroid Drug: by Type USD Million (2023-2028)
  • Figure 46. Global Antithyroid Drug: by Application USD Million (2023-2028)
  • Figure 47. Global Antithyroid Drug: by Distribution Channels USD Million (2023-2028)
  • Figure 48. South America Antithyroid Drug Share (%), by Country
  • Figure 49. Asia Pacific Antithyroid Drug Share (%), by Country
  • Figure 50. Europe Antithyroid Drug Share (%), by Country
  • Figure 51. MEA Antithyroid Drug Share (%), by Country
  • Figure 52. North America Antithyroid Drug Share (%), by Country
  • Figure 53. Global Antithyroid Drug: by Type K Tons (2023-2028)
  • Figure 54. Global Antithyroid Drug: by Application K Tons (2023-2028)
  • Figure 55. Global Antithyroid Drug: by Distribution Channels K Tons (2023-2028)
  • Figure 56. South America Antithyroid Drug Share (%), by Country
  • Figure 57. Asia Pacific Antithyroid Drug Share (%), by Country
  • Figure 58. Europe Antithyroid Drug Share (%), by Country
  • Figure 59. MEA Antithyroid Drug Share (%), by Country
  • Figure 60. North America Antithyroid Drug Share (%), by Country
  • Figure 61. Global Antithyroid Drug: by Type USD/Units (2023-2028)
List of companies from research coverage that are profiled in the study
  • Mylan N.V. (United States)
  • Abbott Laboratories (United States)
  • GlaxoSmithKline plc (United Kingdom)
  • Merck & Co. (United States)
  • AbbVie, Inc. (United States)
  • Pfizer, Inc (United States)
  • RLC LABS (United States)
  • Allergan, plc (United States)
  • advanceCor GmbH. (Germany)
  • Apitope International NV. (Belgium)
Additional players considered in the study are as follows:
AV7 Ltd. (United Kingdom) , Omeros Corp. (United States) , HanAll Biopharma. (South Korea)
Select User Access Type

Key Highlights of Report


May 2023 248 Pages 63 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Antithyroid Drug Market Quantitative research analysis
Global Antithyroid Drug Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Historical year: 2018-2022; Base year: 2022; Forecast period: 2023 to 2028
Companies that are profiled in Global Antithyroid Drug Market are Mylan N.V. (United States), Abbott Laboratories (United States), GlaxoSmithKline plc (United Kingdom), Merck & Co. (United States), AbbVie, Inc. (United States), Pfizer, Inc (United States), RLC LABS (United States), Allergan, plc (United States), advanceCor GmbH. (Germany) and Apitope International NV. (Belgium) etc.
Hospital segment in Global market to hold robust market share owing to "Prevalence of Graves Disease ".
AMA Research predicts that United States Players will contribute to the maximum growth of Global Antithyroid Drug market throughout the forecasted period.

Know More About Global Antithyroid Drug Market Report?

Have a Query? Click Here

Other Related Reports

Yacon Syrup Comprehensive Study by Type (Conventional, Organic), Application (Household, Commercial), Packaging (Bottle, Can, Pouches, Others), Sales Channel (Online, Offline) Players and Region - Gl...
$ 3500
Nasal Antiseptics Comprehensive Study by Type (Lactoperoxidase, Lactoferrin, Interferons, Povidone- Iodine, Alcohols, Others), Application (Hospitals, Laboratories, Clinics, Others), Sales Channel (O...
$ 3500
Aflibercept Drug Comprehensive Study by Application (Diabetic Macular Edoema (DME), Age-Related Macular Degeneration (AMD), Central Retinal Vein Occlusion (CRVO)), Distribution (Hospital Dispensary, ...
$ 3650
Pharmaceutical Lactose Comprehensive Study by Type (Crystalline Monohydrate Lactose, Inhalation Lactose, Granulated Lactose, Spray Dried Lactose, Others), Application (Tablets Manufacturing, Capsule ...
$ 3350
Flu RNA Vaccines Comprehensive Study by Application (Hospitals, Emergency Departments, Clinics, Others), End Users (Adults, Kids), Sales (Hospitals, Retail Pharmacy Stores), Usages (Infectious Diseas...
$ 3500
Linezolid Drug Comprehensive Study by Application (Complex Skin or Skin Soft Tissue Infection (SSTI), Hospital-Acquired Pneumonia (HAP), Community-Acquired Pneumonia (CAP), Vancomycin-Resistant Enter...
$ 3750